Skip to main content
Livermore
Livermore
ZHEN

ARK Invest

Superinvestor

ARK Investment Management LLC

SEC CIK
0001697748
Manager
Cathie Wood
Style
Growth
Latest filing
Aug 14, 2026

ARCT holding history

Arcturus Therapeutics Holdings Inc. in every 13F filed by ARK Invest, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARCT overviewAll 13F holders of ARCTFull Q2 2026 holdings

Shares (Q2 2026)
2,901,635
Value
$19.5M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ARCT by ARK Invest, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,901,635$19.5M0.1%+132,117+4.8%AddedHolders
Q1 20262,769,518$21.4M0.2%+158,419+6.1%AddedHolders
Q4 20252,611,099$16.0M0.1%+738,378+39.4%AddedHolders
Q3 20251,872,721$34.5M0.2%+157,681+9.2%AddedHolders
Q2 20251,715,040$22.3M0.2%−293,440−14.6%ReducedHolders
Q1 20252,008,480$21.3M0.2%+74,629+3.9%AddedHolders
Q4 20241,933,851$32.8M0.3%−167,187−8.0%ReducedHolders
Q3 20242,101,038$48.8M0.4%+136,074+6.9%AddedHolders
Q2 20241,964,964$47.8M0.4%+275,315+16.3%AddedHolders
Q1 20241,689,649$57.1M0.4%−358,038−17.5%ReducedHolders
Q4 20232,047,687$64.6M0.4%+146,141+7.7%AddedHolders
Q3 20231,901,546$48.6M0.4%−5,450−0.3%ReducedHolders
Q2 20231,906,996$54.7M0.4%−78,425−4.0%ReducedHolders
Q1 20231,985,421$47.6M0.3%−27,008−1.3%ReducedHolders
Q4 20222,012,429$34.1M0.3%−169,274−7.8%ReducedHolders
Q3 20222,181,703$32.3M0.2%−122,048−5.3%ReducedHolders
Q2 20222,303,751$45.8M0.3%−80,089−3.4%ReducedHolders
Q1 20222,383,840$64.3M0.3%−88,790−3.6%ReducedHolders
Q4 20212,472,630$91.5M0.3%−56,879−2.2%ReducedHolders
Q3 20212,529,509$120.9M0.3%−355,173−12.3%ReducedHolders
Q2 20212,884,682$97.6M0.2%−447,207−13.4%ReducedHolders
Q1 20213,331,889$137.6M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.